【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of generics
• Generic drugs industry
• Comparison between generic drugs and branded drugs
PART 06: Key leading countries
• US
• China
• India
PART 07: Global pharmaceutical market
• Market overview
• Market size and forecast
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by category
• Simple generics
• Super generics
• Biosimilars
PART 10: Market segmentation by therapeutic application
PART 11: Geographical segmentation
• Global generic drugs market by geographical segmentation 2015-2020
• Generic drugs market in Americas
• Generic drugs market in APAC
• Generic drugs market in EMEA
PART 12: Market drivers
• Patent expiry of top-selling drugs
• Growing acceptance of generic medicines
• Increasing demand in emerging markets
• Social and private health insurance in emerging markets
• Increasing prevalence of diseases
PART 13: Impact of drivers
PART 14: Market challenges
• Adverse effects
• Stringent regulations
• Threat of counterfeit drugs
• Intense competition among vendors
PART 15: Impact of drivers and challenges
PART 16: Market trends
• M&A
• Outsourcing of drug development
• Strategic alliances
PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Teva Pharmaceuticals
• Sandoz
• Allergan
• Mylan
• Sun Pharmaceuticals
• STADA Arzneimittel
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Advantages and features of generic drugs
Exhibit 03: Value chain of generic pharmaceuticals
Exhibit 04: Regulatory bodies and associations for generic drugs in US and Europe
Exhibit 05: Types of drug application
Exhibit 06: Difference between unbranded, branded, and company-branded generics
Exhibit 07: Comparison between generic and branded drugs
Exhibit 08: Key leading countries in the global generic drugs market
Exhibit 09: Major drivers, challenges, and trends in generic drugs market in US
Exhibit 10: Major drivers, challenges, and trends in generic drugs market in China
Exhibit 11: Major drivers, challenges, and trends in generic drugs market in India
Exhibit 12: Global pharmaceutical market 2015-2020 ($ trillions)
Exhibit 13: Drivers, challenges, and trends in global pharmaceutical market
Exhibit 14: Global pharmaceutical and generic drugs market 2015 ($ billions)
Exhibit 15: Global generic drugs market 2015-2020 ($ billions)
Exhibit 16: Distribution of global medicine spending 2015
Exhibit 17: Five forces analysis
Exhibit 18: Global generic drugs market segmentation by category
Exhibit 19: Global biosimilars market 2015-2020 ($ billions)
Exhibit 20: Global generic drugs market segmentation by therapeutic application
Exhibit 21: Global generic drugs market segmentation by therapeutic application 2015
Exhibit 22: Global generic drugs market by geographical segmentation 2015
Exhibit 23: Global generic drugs market revenue by geographical segmentation 2015-2020 ($ billions)
Exhibit 24: Generic drugs market in Americas 2015-2020 ($ billions)
Exhibit 25: Generic drugs market in Americas by country 2015
Exhibit 26: Distribution of medicine spending in North America 2014
Exhibit 27: Distribution of medicine spending in Central and South America 2014
Exhibit 28: Generic drugs market in US 2015-2020 ($ billions)
Exhibit 29: Overview of generic drugs market in US
Exhibit 30: Regulations in US generic drugs market
Exhibit 31: Generic drugs market in APAC 2015-2020 ($ billions)
Exhibit 32: Distribution of medicine spending in APAC 2015
Exhibit 33: Generic drugs market in APAC by country 2015
Exhibit 34: Generic drugs market in China 2015-2020 ($ billions)
Exhibit 35: Generic drugs market in China 2015-2020 ($ billions)
Exhibit 36: Generic drugs market in India 2015-2020 ($ billions)
Exhibit 37: Generic drugs market in India 2015-2020 ($ billions)
Exhibit 38: Regulation in Indian generic drugs market
Exhibit 39: Generic drugs market in Japan 2015-2020 ($ billions)
Exhibit 40: YoY revenue and growth of the global generics drugs market by geography 2015-2020 ($ billions)
Exhibit 41: Generic drugs market in EMEA 2015-2020 ($ billions)
Exhibit 42: Distribution of medicine spending in Africa and Middle East 2015
Exhibit 43: Generic drugs market in Europe 2015-2020 ($ billions)
Exhibit 44: Overview of generic drugs market in Europe
Exhibit 45: Regulations in generic drugs market in Europe
Exhibit 46: Distribution of medicine spending in Europe 2014
Exhibit 47: Generic drugs market in Europe by country 2015
Exhibit 48: Generic drugs market in Germany 2015-2020 ($ billions)
Exhibit 49: Generic drugs market in the UK 2015-2020 ($ billions)
Exhibit 50: Generic drugs market in France 2015-2020 ($ billions)
Exhibit 51: Generic drugs market in Spain 2015-2020 ($ billions)
Exhibit 52: Generic drugs market in Italy 2015-2020 ($ billions)
Exhibit 53: Patent expiry of branded drugs by 2020
Exhibit 54: Impact of drivers
Exhibit 55: Impact of drivers and challenges
Exhibit 56: Global generic drugs market share analysis 2015
Exhibit 57: Top-10 global generic drug manufacturers by market share 2014
Exhibit 58: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 59: Teva Pharmaceuticals: YoY growth rate and revenue of generic medicines segment 2012-2014 ($ billions)
Exhibit 60: Teva Pharmaceuticals: Geographic segmentation by revenue 2014 (generic medicines segment)
Exhibit 61: Teva Pharmaceuticals: YoY growth rate and revenue of Copaxone 2012-2014 ($ billions)
Exhibit 62: Teva Pharmaceuticals: YoY growth rate and revenue of Azilect 2012-2014 ($ millions)
Exhibit 63: Teva Pharmaceuticals: SWOT analysis
Exhibit 64: Sandoz: Business segmentation by revenue 2014
Exhibit 65: Sandoz: YoY revenue of retail generics segments 2013-2014 ($ billions)
Exhibit 66: Sandoz: SWOT analysis
Exhibit 67: Allergan: Business segmentation by revenue 2014
Exhibit 68: Allergan: YoY growth rate and revenue of North American generics and international segment 2012-2014 ($ billions)
Exhibit 69: Allergan: Geographic segmentation by revenue 2014 (North American generics and international segment)
Exhibit 70: Allergan: YoY revenue of Lo Loestrin Fe 2013-2014 ($ millions)
Exhibit 71: Allergan: SWOT analysis
Exhibit 72: Mylan: Business segmentation 2014 by revenue
Exhibit 73: Mylan: YoY growth rate and revenue of generics segment 2012-2014 ($ billion)
Exhibit 74: Mylan: Geographical segmentation by revenue 2014 (generics segment)
Exhibit 75: Mylan: SWOTS analysis
Exhibit 76: Sun Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 77: Sun Pharmaceuticals: Geographical segmentation by revenue 2014
Exhibit 78: Sun Pharmaceuticals: SWOT analysis
Exhibit 79: STADA Arzneimittel: Business segmentation by revenue 2014
Exhibit 80: STADA Arzneimittel: YoY growth rate and revenue of generics segment 2012-2014 ($ billions)
Exhibit 81: STADA Arzneimittel: Geographical segmentation by revenue 2014 (generics segment)
Exhibit 82: STADA Arzneimittel: YoY growth rate and revenue of Omeprazole 2012-2014 ($ millions)
Exhibit 83: STADA Arzneimittel: YoY growth rate and revenue of Diclofenac 2012-2014 ($ millions)
Exhibit 84: STADA Arzneimittel: YoY revenue of Tilidine 2013-2014 ($ millions)
Exhibit 85: STADA Arzneimittel: YoY growth rate and revenue of Phospholipide 2013-2014 ($ millions)
Exhibit 86: STADA Arzneimittel: SWOT analysis
【レポート販売概要】
■ タイトル：ジェネリック医薬品の世界市場2016-2020■ 英文：Global Generic Drugs Market 2016-2020
■ 発行日：2016年5月26日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9573
■ 調査対象地域：グローバル
- 世界のオピオイド市場GBI Research’s latest report, "Opioids Overview to 2021 - An Assessment of Pain Management and Dependence" discusses the use of opioids as potent analgesics for the treatment of cancer and non-cancer pain and examines the management of opioid dependence in the US, the UK, Germany, Spain, Italy, France, Australia, Japan, India and China. Analysis pertaining to the prescribed opioid users, treatment …
- 2014年戦略提言：ロタウイルスの診断検査市場The report presents a detailed analysis of the Rotavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rotavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- ポリアリールスルホン（PAS）の世界市場：製品別（ポリフェニルスルホン（PPSU）、ポリエーテルイミド（PEU）、ポリエーテルスルホン（PESU）、地域別、セグメント予測The global polyarylsulfone market is expected to reach USD 2.9 billion by 2025, according to a new report by Grand View Research, Inc. Growing application in medical device & technology applications such as blood filtration membranes, dental instruments, surgical devices, and medium-sized containers emerged as a significant demand driver for the PAS market. Polyarylsulfone (PAS) share numerous app …
- 消費者向けドローンの世界市場2016-2020About Consumer Drone Consumer drones are used to capture photos and shoot videos. They are also used as toys. Consumer drones are capable of capturing high-speed actions, distinct objects, and are designed for rugged conditions, including extreme weather. Consumer drones are equipped with GPS tracking and high-quality cameras that allow users to take photos of distinct objects, without any threat …
- 世界の電子タバコ市場動向：Global E-cigarette Market 2014-2018TechNavio forecasts The Global E-cigarette Market 2014-2018 with a CAGR of 30.56 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provi …
- K-12教育向け技術の東南アジア市場2016-2020About K-12 Education Technology The AEC was established with an aim to transform the ASEAN into a production base with a high competitive advantage and stability over the rest of the world. The community focuses on the economic, political, and socio-cultural development of its 10-member states. A major focus is on improving tertiary education and employability in the region. The conducive conditio …
- 飼料用酵母の世界市場予測（～2022年）The feed yeast market is projected to grow at a CAGR of 8.21% during the forecast period, to reach a projected value of USD 602.8 Million by 2022. The demand for feed yeast is largely dependent on the increase in demand for livestock produce such as meat & meat products and dairy products. The rise in awareness about the health benefits of yeast such as enhanced gut flora, improved immune system, …
- 心臓バイオマーカーの世界市場分析：タイプ別（トロンポニン、クレアチンキナーゼ-MB（CK-MB）、ナトリウム利尿ペプチド-B型ナトリウム利尿ペプチド（BNP）･N末端プロb型ナトリウム利尿ペプチド（NT-proBNP）、ミオグロビン、虚血修飾アルブミン（IMA）、心臓型脂肪酸結合タンパク質（H-FABP）、LDHアイソザイム）、用途別（急性冠動脈症候群、心筋梗塞、うっ血性心不全、心筋症、虚血、心筋炎、心房細動）、エンドユーザー別、地域別、セグメント予測The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth during the forecast period from 2016 to 2024. Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease d …
- 2014年戦略提言：アメリカのポイントオブケア（POC）脂質検査市場This new 305-page report from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective bu …
- 世界主要国におけるHIV/AIDS検査市場2015The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIV Ag, HTLV-I/II, Western Blot and other confirmatory …
- ストレートヘアアイロンの世界市場：プレートタイプ別（セラミック、チタン、トルマリン、その他）、最終用途別（家庭用、商用）、流通経路別（オンライン、オフライン）The Hair Straightener market size was valued at $591.2 million in 2018 and is expected to reach $861.1 million by 2026, registering a CAGR of 4.9% from 2018 to 2025. The global Hair Straightener market is segmented on the basis of plate type, end use, distribution channel and region. Based on plate type, the market is classified into ceramics, titanium, tourmaline and others. By end use, the marke …
- 美容レーザーおよびエネルギーデバイスの世界市場：製品別（レーザーリサーフェシングデバイス、ボディコンタリングデバイス、および審美眼科デバイス）、技術別（レーザーベースのテクノロジー、光ベースのテクノロジー、エネルギーベースのテクノロジー）、用途別（脱毛、瘢痕除去、スキンリサーフェシング、スキン若返り、肌の引き締めなど）、エンドユーザー別（複数の専門センター、スタンドアロンセンター、および美容外科センターとクリニック）The global aesthetic lasers and energy devices market was valued at $3962.4 million in 2018 and is expected to reach $9534.6 million by 2026, registering a CAGR of 10.5% from 2019 to 2026. Aesthetic lasers and energy devices are widely being used for several cosmetic and medical applications including skin treatments and body defects. These devices offer minimally invasive treatments. They help in …
- 電気自動車向けリレーの世界市場2019-2023About this market The increase in electronics and safety requirements in electric vehicles is one of the key factors expected to trigger the electric vehicle relays market growth during the forecast period. The rising demand for relays is being further supported by the increasing requirement for safety components including anti-locking systems (ABS), electronic brakeforce distribution (EBD), and a …
- パーソナルアイデンティティー管理の世界市場：アクセス制御、コンテンツ管理、サービスMarketsandMarkets forecasts the Personal Identity Management market size to grow from USD 7.37 Billion in 2016 to USD 12.76 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 11.61%. The constant pressure of managing data breaches along with the need to reduce costs has led enterprises of all sizes to adopt Personal Identity Management applications for data management. Also, cloud-based d …
- SDN及びNFVの世界市場2015-2020Software defined networking (SDN) and virtualization are poised to transform network and service architecture thanks to improvements in technologies that offer improved performance and lower costs. As the border between Cloud Computing and network infrastructure continues to blur, so does the demarcation between the network as a whole and those network elements (servers, terminals, etc.) that comp …
